I. D. Werner

Risk Factors for Locoregional Recurrence Among Breast Cancer Patients: Results From International Breast Cancer Study Group Trials I Through VII

Arne Wallgren, Marco Bonetti, Richard D. Gelber et al. · Journal of Clinical Oncology · 2003 · 273 citations

Medicine, Oncology, Breast Oncology +16

Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience

Gilles Berclaz, S. Li, Karen N. Price et al. · Annals of Oncology · 2004 · 260 citations · Full text

Medicine, Oncology, Surgery +9

Randomised trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma.

Michael Madden, J E J Krige, Scott Bailey et al. · Gut · 1993 · 135 citations · Full text

Medicine, Oncology, Pharmacology +10

Prospective randomized trial of combined oncological therapy for gastric carcinoma

D M Dent, I. D. Werner, Ben Novis et al. · Cancer · 1979 · 115 citations · Full text

Medicine, Oncology, Surgery +13

A randomized, placebo-controlled, double-blind phase 2 study of docetaxel compared to docetaxel plus zosuquidar (LY335979) in women with metastatic or locally recurrent breast cancer who have received one prior chemotherapy regimen

Paul Ruff, Daniel Vorobiof, J. P. Jordaan et al. · Cancer Chemotherapy and Pharmacology · 2009 · 83 citations

Medicine, Oncology, Pharmacotherapy +9